Readthrough of SCN5A Nonsense Mutations p.R1623X and p.S1812X Questions Gene-therapy in Brugada Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|17|1|50-58

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.17, Iss.1, 2017-07, pp. : 50-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluvoxamine: Provocation of Brugada syndrome ECG in a patient with an SCN5A p.W822X nonsense mutation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1301, 2010-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases

By Arulkumaran Nishkantha   Unwin Robert J   Tam Frederick WK  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 897-915

Informa Healthcare

Access to resources Recommend Favorite

Antineoplastics: Brugada syndrome? and immediate hypersensitivity reaction: case report

By  

Reactions Weekly, Vol. 1, Iss. 1360, 2011-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

P2X Receptors and Inflammation

By  

Current Medicinal Chemistry, Vol. 22, Iss. 7, 2015-03 ,pp. : 866-877

Bentham Science Publishers

Access to resources Recommend Favorite

P2X Receptors and Diabetes

By  

Current Medicinal Chemistry, Vol. 22, Iss. 7, 2015-03 ,pp. : 891-901

Bentham Science Publishers

Access to resources Recommend Favorite